YUNKANG GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.66 HKD | -2.02% |
|
-2.20% | -13.33% |
| 13/05 | Yunkang Group Sees Potential in Outsourcing Lab Testing Services for China's Public Hospitals | MT |
| 05/04 | Everbest Machinery Industry to Set Up 30 Million Yuan Joint Venture | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 98Cr 14Cr 105.9Cr 1.13TCr | Sales 2025 * | 108.95Cr 15Cr 117.81Cr 1.26TCr | Capitalization | 605.45Cr 84Cr 654.71Cr 7TCr |
|---|---|---|---|---|---|
| Net income 2024 * | -2.5Cr -34.64L -2.7Cr -29Cr | Net income 2025 * | 3Cr 41.56L 3.24Cr 35Cr | EV / Sales 2024 * | 5.62 x |
| Net cash position 2024 * | 55Cr 7.58Cr 59Cr 632.52Cr | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 5.56 x |
| P/E ratio 2024 * |
-252
x | P/E ratio 2025 * |
201
x | Employees | 1,510 |
| Yield 2024 * |
33.3% | Yield 2025 * |
33.6% | Free-Float | 25.97% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.02% | ||
| 1 week | -2.20% | ||
| Current month | -3.96% | ||
| 1 month | -3.62% | ||
| 3 months | -8.58% | ||
| 6 months | -11.17% | ||
| Current year | -13.33% |
1 week
10.66
11.04
1 month
10.6611.12
Current year
10.0412.30
1 year
10.0414.88
3 years
6.6019.18
5 years
6.6019.18
10 years
6.6019.18
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Zhang
CEO | Chief Executive Officer | 52 | 20/18/20 |
Ying Jia Lin
DFI | Director of Finance/CFO | 45 | 07/21/07 |
Tie Ding Wang
PRN | Corporate Officer/Principal | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shi You Yu
BRD | Director/Board Member | 67 | - |
Shao Hua Xie
BRD | Director/Board Member | 52 | - |
Ping Hui Wang
BRD | Director/Board Member | 64 | 30/23/30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/24/16 | 10.66 | -2.02% | 45 000 |
| 14/24/14 | 10.88 | -0.18% | 44,500 |
| 13/24/13 | 10.9 | 0.00% | 35,000 |
| 10/24/10 | 10.9 | 0.00% | 56,000 |
| 09/24/09 | 10.9 | -0.91% | 53,500 |
Delayed Quote Hong Kong S.E., May 16, 2024 at 01:38 pm IST
More quotes
Yunkang Group Ltd is a China-based Company mainly engaged in the provision of diagnosis testing services. The Company operates three segments. Diagnosis Testing segment provides diagnosis testing to hospital and non-medical clients, mainly including routine diagnostic testing, routine pathological examination, infectious disease diagnostic testing, genetic disease diagnostic testing and early cancer detection. Hospital Management Business segment provides management services for the community clinics. Research & Development Institution segment is engaged in the research and development of testing kits. The Company primarily provides services for hospitals and other medical institutions, and commercial entities such as financial institutions and insurance companies.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.07
CNY
Average target price
12.93
CNY
Spread / Average Target
+28.35%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.33% | 84Cr | |
| -15.71% | 856.91Cr | |
| +67.50% | 430.28Cr | |
| -9.63% | 247.46Cr | |
| -2.16% | 246.23Cr | |
| -42.54% | 231.37Cr | |
| -6.49% | 193.23Cr | |
| -20.45% | 152.61Cr | |
| -41.24% | 120Cr | |
| +10.26% | 113.6Cr |
- Stock Market
- Equities
- 2325 Stock
